Last reviewed · How we verify
NCT06875544: Randomized
Clinical Performance of High Viscosity Bioactive Injectable Composite in Deep Marginal Elevation Randomized Controlled Trail
NA trial testing Beautifil F00 in DME in 50 participants. Not yet recruiting.
1 April 2026
Quick facts
| Lead sponsor | Future University in Egypt |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | single group |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 50 |
| Start date | 1 March 2025 |
| Primary completion | 1 April 2026 |
| Estimated completion | 1 April 2026 |
Drugs / interventions tested
- Beautifil F00
- G-aenial Universal Injectable Flowable Composite
Conditions studied
- DME — all drugs for DME →
- Dental — all drugs for Dental →
- Deep Margin Elevation — all drugs for Deep Margin Elevation →
Sponsor
Future University in Egypt
Who can join
Adults 20 to 50, any sex, with DME or Dental. Healthy volunteers can join.
What's being measured
Primary outcomes are the specific endpoints the trial is designed to prove or disprove.
-
Recurrent caries
Time frame: T (Time): T1: 1 week hours Baseline T2: 6 Months T3: 12 Months
* 0: no evidence of caries continuous along the margin * 1: caries evident continuous with the margin of restoration
Sponsor's own description
Using a bioactive resin composite in subgingival Class II cavities can provide enhanced caries resistance by releasing multiple ions, including fluoride. This approach offers greater resistance to caries due to the incorporation of surface pre-reacted glass filler (S-PRG) technology (Imazato, Nakatsuka et al., 2023). This type of composite may improve the outcomes of deep subgingival margin elevation, benefiting both restorative success and periodontal health.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06875544
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Future University in Egypt trials
Trials by the same sponsor.
- NCT07347925 — Effect of Pre-Hospital ARNI Therapy on Short-Term Outcomes in HFrEF · recruiting
- NCT07129720 — Educational Program to Improve Dental Interns, Knowledge ,Attitude and Awareness Toward Molar Incisor Hypo-mineralizatio · NA · completed
- NCT07193342 — Effect of Computer-controlled vs. Conventional Injection on Pain and Anxiety in Children · NA · completed
- NCT06950762 — Aesthetic Performance of Two Injectable Resin Composites in Class V Cavities: A Randomized Clinical Trial · NA · not yet recruiting
- NCT06882343 — Performance of Bioactive Low Viscosity Composite in Deep Marginal Elevation Restorations · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06875544 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Future University in Egypt
- Last refreshed: 8 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06875544.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing